Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D03301 (
PDL
)
658
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
During cellular senescence in vitro, the cells do not respond mitogenically to serum growth factors at high population doubling levels.
Phospholipase C
activity in low
PDL
IMR 90 cells showed a 4.7-fold stimulation in response to 10% serum compared to 3.3-fold in high
PDL
cells when measured in whole cell extracts. Immunoaffinity purified tyrosine phosphorylated protein fraction showed a greater increase (5.2-fold) in phospholipase C activity in low
PDL
than high
PDL
cells (2.1-fold) in response to serum. Serum stimulated PLC gamma 1 activity was diminished in high
PDL
cells. Immunokinase assay of PLC gamma 1 immunoprecipitates from serum stimulated IMR 90 fibroblasts suggested that diminished enzymatic activity in high
PDL
cells is not due to less receptor coupled tyrosine phosphorylated PLC gamma 1 enzyme. Serum stimulated [3H]thymidine incorporation into DNA declined in parallel with the activity of PLC gamma 1, suggesting that its activation might play significant roles in this in vitro model for cellular senescence.
...
PMID:Decline of signal transduction by phospholipase C gamma 1 in IMR 90 human diploid fibroblasts at high population doubling levels. 195 65